Literature DB >> 7523635

Quantitative imaging of estrogen and progesterone receptors, estrogen-regulated protein, and growth fraction: immunocytochemical assays in 52 meningiomas. Correlation with clinical and morphological data.

P Bouillot1, J F Pellissier, B Devictor, N Graziani, N Bianco, F Grisoli, D Figarella-Branger.   

Abstract

Quantitative imaging of estrogen receptors (ER's), progesterone receptors (PR's), estrogen-regulated protein (pS2), and growth fraction (Ki67) immunocytochemical assays were performed in 52 meningiomas. The results were correlated with clinical (age, sex, hormonal status, and tumor volume and location) and morphological (histological types and grades) data. The authors observed a lack of ER's in all meningiomas but the presence of PR's in 53% of these meningiomas. The immunoreactivity was restricted to tumor cell nuclei. The PR immunocytochemical assay was correlated with tumor location, histological type, histological grade, and pS2 immunocytochemical assay, but not with Ki67 immunocytochemical assay; high PR content was observed in cisternae, transitional, meningothelial, and low-grade meningiomas. Only 11 meningiomas showed more than 1% Ki67 immunoreactive nuclei. These meningiomas were usually located in the convexity and were of high histological grade. Estrogen-regulated protein immunoreactivity was observed in 34 meningiomas but the number of immunoreactive nuclei was low. The pS2 immunocytochemical assay was not related to clinicopathological features but was preferentially observed in PR-negative meningiomas. The results of this study are compared with those previously reported, and the function and regulation of PR's in meningiomas is discussed. The results indicate that 1) regulation of PR's and pS2 proteins in meningiomas differs from regulation in estrogen-dependent tissues such as breast or endometrium; 2) interruption of hormonal therapy in women presenting with a meningioma is not absolutely necessary; 3) meningiomas have different biological properties according to their clinicopathological features; and 4) future studies of hormonal clinical trials should be performed on well-defined meningioma subgroups.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7523635     DOI: 10.3171/jns.1994.81.5.0765

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  9 in total

1.  Fatty acid synthase is a predictive marker for aggressiveness in meningiomas.

Authors:  Keishi Makino; Hideo Nakamura; Taku-ichiro Hide; Shigetoshi Yano; Jun-Ichiro Kuroda; Ken-Ichi Iyama; Jun-Ichi Kuratsu
Journal:  J Neurooncol       Date:  2012-06-29       Impact factor: 4.130

2.  Expression of estrogen receptors alpha and beta in human meningiomas.

Authors:  R S Carroll; J Zhang; P M Black
Journal:  J Neurooncol       Date:  1999-04       Impact factor: 4.130

3.  Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression.

Authors:  Katariina Korhonen; Tiina Salminen; Jani Raitanen; Anssi Auvinen; Jorma Isola; Hannu Haapasalo
Journal:  J Neurooncol       Date:  2006-05-13       Impact factor: 4.130

4.  Progestin-related WHO grade II meningiomas behavior-a single-institution comparative case series.

Authors:  Antoine Devalckeneer; Rabih Aboukais; Maxime Faisant; Philippe Bourgeois; Vannod-Michel Quentin; Claude-Alain Maurage; Fabienne Escande; Jean-Paul Lejeune
Journal:  Neurosurg Rev       Date:  2021-11-30       Impact factor: 3.042

5.  The contribution of cytogenetics to the histogenesis of meningeal hemangiopericytoma.

Authors:  H Zattara-Cannoni; M O North; D Gambarelli; D Figarella-Branger; N Graziani; F Grisoli; A M Vagner-Capodano
Journal:  J Neurooncol       Date:  1996-08       Impact factor: 4.130

6.  Proliferation rate of intracranial meningiomas as defined by the monoclonal antibody MIB-1: correlation with peritumoural oedema and other clinicoradiological and histological characteristics.

Authors:  Paulo Henrique Aguiar; Ana Maria Tsanaclis; Oswaldo Inácio Tella; José Pindaro Plese
Journal:  Neurosurg Rev       Date:  2003-04-08       Impact factor: 3.042

7.  Progesterone-receptor index in meningiomas: correlation with clinico-pathological parameters and review of the literature.

Authors:  Stefan Wolfsberger; Soroush Doostkam; Hans-Gerd Boecher-Schwarz; Karl Roessler; Michael van Trotsenburg; Johannes A Hainfellner; Engelbert Knosp
Journal:  Neurosurg Rev       Date:  2004-05-27       Impact factor: 3.042

8.  Rhabdoid meningioma: clinical features and MR imaging findings in 15 patients.

Authors:  E Y Kim; Y C Weon; S T Kim; H-J Kim; H S Byun; J-I Lee; J H Kim
Journal:  AJNR Am J Neuroradiol       Date:  2007-09       Impact factor: 3.825

9.  A systematic review and meta-analysis of the association between cyproterone acetate and intracranial meningiomas.

Authors:  Keng Siang Lee; John J Y Zhang; Ramez Kirollos; Thomas Santarius; Vincent Diong Weng Nga; Tseng Tsai Yeo
Journal:  Sci Rep       Date:  2022-02-04       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.